AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CICLOSPORIN
34 registrations across 7 African markets— 19 active
Markets with CICLOSPORIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Sandimmun Neoral Capsule soft 50mg Capsule, Soft | 🇰🇪Kenya | NVS Kenya Limited | active | Jul 2031 |
| Sandimmun Neoral Capsules 25mg Capsule, Soft | 🇰🇪Kenya | Novartis | active | Apr 2031 |
| SANDIMMUM NEORAL 100MG SOFT GELATIN CAPSULES | 🇷🇼Rwanda | CATALENT GERMANY EBERBACH GmbH, | active | Jul 2029 |
| SANDIMMUM NEORAL 25MG SOFT GELATIN CAPSULES | 🇷🇼Rwanda | CATALENT GERMANY EBERBACH GmbH, | active | Jul 2029 |
| Sandimmun Neoral® 25 mg Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Nov 2028 |
| SANDIMUN NEORAL CAPSULES | 🇬🇭Ghana | — | active | Dec 2026 |
| SANDIMUN NEORAL CAPSULES | 🇬🇭Ghana | — | active | Dec 2026 |
| Sandiummum Neoral 50 mg Capsules Capsule | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2026 |
| Sandiummum Neoral 100 mg Capsules** Capsule | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2026 |
| SANDIMMUN AMPOULES 50 mg PER 1 ml | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | suspended | Apr 2026 |
| CIPLA-CYCLOSPORINE-25 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Sept 2025 |
| CIPLA-CYCLOSPORINE-50 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Sept 2025 |
| IMUSPORIN ORAL SOLUTION | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Sept 2025 |
| CIPLA-CYCLOSPORINE ORAL SOLUTION | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA-CYCLOSPORINE-100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| IMUSPORIN-25 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| IMUSPORIN-50 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| IMUSPORIN-100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ATOPICA 100 mg/ML ORAL SOLUTION FOR CATS AND DOGS | 🇿🇦South Africa | Elanco Animal Health (Pty) Ltd | suspended | Nov 2023 |
| SANDIMMUN 250MG/5ML SOLUTION INJECTABLE BOITE DE 10 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Apr 2022 |
| NEORAL 50MG OVULE BOITE DE 50 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2022 |
| NEORAL 100MG OVULE BOITE DE 50 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2022 |
| NEORAL 25MG OVULE BOITE DE 50 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2022 |
| SANDIMMUN NEORAL 100MG/ML SOLUTE BUVABLE FLACON DE 50ML | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2022 |
| SANDIMMUN NEORAL 25 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| CYCLAVANCE | 🇿🇦South Africa | Virbac RSA (Pty) Ltd | active | Jan 1900 |
| SANDIMMUN NEORAL | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| ATOPICA 25 | 🇿🇦South Africa | Elanco Animal Health (Pty) Ltd | active | Jan 1900 |
| ATOPICA 100 | 🇿🇦South Africa | Elanco Animal Health (Pty) Ltd | active | Jan 1900 |
| SANDIMMUN NEORAL 100 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIMMUNE | 🇿🇦South Africa | Intervet South Africa (Pty) Ltd | active | Jan 1900 |
| ATOPICA 50 | 🇿🇦South Africa | Elanco Animal Health (Pty) Ltd | active | Jan 1900 |
| Sandimmun Neoral Capsules, soft | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| Sandimmun Neoral Capsules, soft | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
CICLOSPORIN in Africa — Regulatory Overview
CICLOSPORIN is registered across 7 African markets with 34 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Côte d'Ivoire, Nigeria, Kenya and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 34 registrations, 19 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.